CRS 2015: Therapeutic Advances in Hypercholesterolemia: Examining the Role of PCSK-9 Inhibitors in Addressing Unmet Needs

Faculty Member Michael J. Bloch, MD, FACP, FASH, FVM, Associate Professor, Department of Internal Medicine, University of Nevada School of Medicine; Medical Director, Vascular Care, Renown Institute for Heart and Vascular Health talks about PCSK9 with Co-Chair Edward Shahady, MD, FAAFP, ABCL.

Submit Feedback

Name